drugset / Trial / NCT00215384

Study in Patients With COPD

NCT00215384

Phase 2 Completed 35 enrolled Dey
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective compared to the control drug.

Timeline

Start
Primary completion
2003-04
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified